BSX vs. COR: Boston Scientific vs. Cencora Stock Comparison
How do Boston Scientific (BSX) and Cencora (COR) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Cencora (COR) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while COR is classified in Health Care Providers & Services.
| Profile Item | BSX | COR |
|---|---|---|
| Name | Boston Scientific Corp. | Cencora Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Distributors |
| Market Capitalization | 61.96 billion USD | 63.65 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | April 4, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | COR |
|---|---|---|
| Total Return (1Y) | -55.98% | -3.53% |
| Total Return (3Y, Annualized) | -5.05% | 21.62% |
| Total Return (5Y, Annualized) | 0.57% | 24.10% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | COR |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 31.90% |
| Beta (5Y) | 0.57 | 0.56 |
| Max Drawdown (5Y) | -61.55% | -32.44% |
| Avg. Volume (3M) | 19.73M | 1.29M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | COR |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | -0.24 |
| Sortino Ratio (1Y) | -1.80 | -0.30 |
Profitability
ROE (TTM)
Cencora (COR) at 129.01% clears its industry range for ROE, a sharper capital-efficiency signal than Boston Scientific (BSX) at 14.12%, which is closer to a typical peer reading.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
COR
Health Care Equipment & Services industry group
129.01%
- COR
- 129.01%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of Cencora (COR) at 1.03%, which keeps about the industry-typical share.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
COR
Health Care Equipment & Services industry group
1.03%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- COR
- 1.03%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Cencora (COR) at 1.27%, which runs around its industry’s norm.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
COR
Health Care Equipment & Services industry group
1.27%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- COR
- 1.27%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | COR |
|---|---|---|
| ROE (TTM) | 14.12% | 129.01% |
| ROA (TTM) | 5.87% | 3.57% |
| Net Margin (TTM) | 16.62% | 1.03% |
| Operating Margin (TTM) | 19.05% | 1.27% |
| Gross Margin (TTM) | 67.98% | 4.09% |
Growth
Revenue Growth
Only one side can be read here: Boston Scientific (BSX) reports revenue growth of 19.87%, ranked against its industry; Cencora (COR) has no revenue growth figure this period.
EPS Growth
Both companies show strong earnings momentum, but Cencora (COR) at 125.50% is the standout with EPS growth above its industry range; Boston Scientific (BSX) at 55.20% also sits in the top quartile.
Growth Metrics
| Metric | BSX | COR |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | -- |
| Revenue Growth (3Y CAGR) | 16.54% | -- |
| EPS Growth (YoY) | 55.20% | 125.50% |
| EPS Growth (3Y CAGR) | 62.75% | 28.15% |
Financial Strength
Current Ratio (MRQ)
Both Boston Scientific (BSX) at 1.37 and Cencora (COR) at 0.94 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
COR
Health Care Equipment & Services industry group
0.94
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COR
- 0.94
- Min
- 0.30
Debt / Equity (MRQ)
Boston Scientific (BSX) at 0.46 is near its industry mid-range for debt-to-equity ratio, while Cencora (COR) at 3.06 sits above its benchmark range, pointing to a heavier debt load relative to equity.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
COR
Health Care Equipment & Services industry group
3.06
- COR
- 3.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | COR |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 0.94 |
| Debt / Equity (MRQ) | 0.46 | 3.06 |
| Net Debt / EBITDA | 2.04 | 1.12 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a yield of 0.71%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COR
Health Care Equipment & Services industry group
0.71%
- COR
- 0.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a payout of 17.45%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COR
Health Care Equipment & Services industry group
17.45%
- COR
- 17.45%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | COR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.71% |
| Dividend Payout Ratio (TTM) | 0.00% | 17.45% |
Valuation
P/E Ratio (TTM)
Both Boston Scientific (BSX) at 18.04 and Cencora (COR) at 18.58 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
COR
Health Care Equipment & Services industry group
18.58
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- COR
- 18.58
- Min
- 4.21
P/S Ratio (TTM)
Cencora (COR) at 0.19 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — COR costs less per dollar of sales, though read it alongside growth and margins.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
COR
Health Care Equipment & Services industry group
0.19
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- COR
- 0.19
- Min
- 0.03
P/B Ratio (MRQ)
Boston Scientific (BSX) at 2.42 sits near its industry’s typical P/B ratio, while Cencora (COR) at 17.29 prices above its benchmark range — COR looks rich relative to book.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
COR
Health Care Equipment & Services industry group
17.29
- COR
- 17.29
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | COR |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 18.58 |
| P/S Ratio (TTM) | 2.94 | 0.19 |
| P/B Ratio (MRQ) | 2.42 | 17.29 |
| Free Cash Flow Yield (TTM) | 4.02% | 2.81% |